- News & Analysis
- Home
- Latest News
- Reports
- Podcast
- The CVC Funding Round Database
- The CVC Directory
- University
- Video
- Subscribe
- Newsletters
- Events
Page 173
Corporates get into Headspace for $93m series C
Chernin Group has returned for the meditation platform's $93m series C round, while Bennett Coleman & Co took part as a new investor.
Feb 13, 2020Fenergo finishes up $80m round
ABN Amro Ventures added to a first tranche provided by DXC Technology, in a round that valued the financial services management platform at approximately $800m.
Feb 13, 2020Hazelcast heightens series D to $50m
The computing platform developer has expanded a round backed by Capital One Growth Ventures from $21.5m to $50m.
Feb 13, 2020Neo Career recruits corporates for new funding
Existing backers Mynavi and Link and Motivation were among the investors that backed a $41.4m round for the recruitment service provider.
Feb 13, 2020SiriusXM gets serious with $75m SoundCloud investment
SoundCloud has received $75m from SiriusXM following an advertising partnership agreement with its Pandora subsidiary in 2019.
Feb 12, 2020Carbon Relay receives Insight with $65m investment
The app optimisation platform developer has added $65m from Insight Partners to the Foxconn-backed series A it raised early last year.
Feb 12, 2020Vezeeta eases into $40m series D
Gulf Capital led a round that boosted the Crescent Enterprises-backed medical booking platform's total funding to more than $63m.
Feb 12, 2020Sonoma sends for Lyell in $40m series A
Sonoma Biotherapeutics has emerged from stealth with $40m to develop regulatory T-cell therapies for autoimmune and degenerative diseases.
Feb 10, 2020Pepperfry cooks up $40m series F round
Pidilite Industries led a $40m round for Pepperfry that included existing backer Bertelsmann, lifting the furniture retailer's overall funding to $235m.
Feb 10, 2020Sonoma sends for Lyell in $40m series A
Sonoma Biotherapeutics has emerged from stealth with $40m from investors including Lyell Immunopharma and is developing regulatory T-cell therapies for autoimmune and degenerative diseases.
Feb 10, 2020About us
GCV provides the global corporate venturing community and their ecosystem partners with the information, insights and access needed to drive impactful open innovation. Across our three services - News & Analysis, Community & Events, and the GCV Institute - we create a network-rich environment for global innovation and capital to meet and thrive. At the heart of our community sits the GCV Leadership Society, providing privileged access to all our services and resources.
Navigation
test regLogin
Not yet subscribed?
We use cookies to enhance your browsing experience and analyse our traffic. By clicking "Accept All", you consent to our use of cookies. Accept Read MorePrivacy & Cookies PolicyPrivacy Overview
This website uses cookies to improve your experience while you navigate through the website. Out of these, the cookies that are categorized as necessary are stored on your browser as they are essential for the working of basic functionalities of the website. We also use third-party cookies that help us analyze and understand how you use this website. These cookies will be stored in your browser only with your consent. You also have the option to opt-out of these cookies. But opting out of some of these cookies may affect your browsing experience.Necessary cookies are absolutely essential for the website to function properly. This category only includes cookies that ensures basic functionalities and security features of the website. These cookies do not store any personal information.Any cookies that may not be particularly necessary for the website to function and is used specifically to collect user personal data via analytics, ads, other embedded contents are termed as non-necessary cookies. It is mandatory to procure user consent prior to running these cookies on your website.


